Vitamin B3 in the Treatment of Diabetes Mellitus: Case Reports and Review of the Literature

References

• Noikos IN. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes 1986; 35: 1302–4
   PubMedGoogle Scholar
• Gillery P, et al. Glycation of proteins as a source of superoxide. Diabete et Metabolisme 1988; 14: 25. (Does oxygen free radical increased formation explain longterm complications of diabetes mellitus?. Med Hyp 1989; 29: 47–50
   PubMed Web of Science ®Google Scholar
• Salmon S, et al. Immunological detection of low-density lipoproteins modified by malondialdehyde in vitro or in vivo. Biochimica Biophysica Acta 1987; 920: 215
   PubMedGoogle Scholar
• Arai K, et al. Increase in the glycosylated form of erythrocyte Cu-Zn superoxide dismutase in diabetes and close association of the nonenzymatic glycosylation with the enzyme activity. Biochemica Biophysica Acta 1987; 924: 292
   PubMedGoogle Scholar
• Staroseltseva L. K., et al. Lipid peroxidation in patients with type I diabetes mellitus. Problemy Endokrinologii 1986; 32: 19
   PubMedGoogle Scholar
• Bindoli A. Lipid peroxidation in mitochondria. Free Radical Biology and Med 1988; 5: 247–61
   PubMed Web of Science ®Google Scholar
• Hayaishi O, . Metabolic and Functional Significance of Prostaglandins in Lipid Peroxide Research. Lipid Peroxides and Medicine, K Yagi, et al. Academic Press, New York 1982; 41–53
   Google Scholar
• Satao Y, et al. Lipid peroxides levels of plasma of diabetic patients. Bio Chem Med 1979; 21: 104–7
   Google Scholar
• Nishigaki I, et al. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1978; 25: 373–8
   Google Scholar
• Schaufstetter IU. Oxidant injury of cell. J Clin Invest 1986; 77: 1312–20
   PubMedGoogle Scholar
• Spragg RF. Alterations in ATP and energy charge in cultured endothelial and P388D following oxidant injury. J Clin Invest 1985; 76: 1471–6
   PubMed Web of Science ®Google Scholar
• Wang J, et al. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thtomboxane by cultured endothelial cells; protective effect of antioxidant. Free Radical Biol and Med 1989; 7: 243–9
   PubMed Web of Science ®Google Scholar
• Karpen C. W., et al. Restoration of prostacyclin thromboxane A2 balance in diabetic rat: influence of vitamin E. Diabetes 1982; 31: 947–51
   Web of Science ®Google Scholar
• Slonim A, et al. Modification of chemically induced diabetes in rats by vitamin E: supplementation minimizes and depletion enhances development of diabetes. J Clin Invest 1983; 71: 1282–8
   PubMedGoogle Scholar
• Robbins MT. Protection against STZ induced diabetes by superoxide dismutase. Diabetologia 1980; 18: 55–8
   PubMedGoogle Scholar
• Higuichi Y. Lipid peroxides and â-tocopherol in rat streptozotocin-induced diabetes mellitus. Acta Med Okayama 1982; 36: 165–75
   PubMedGoogle Scholar
• Sydenstricker VP. Avitaminosis occurring in diabetic patients under insulin therapy. JAMA 1939; 113(2)2137–8
   Google Scholar
• Vilter RW. Relationship between nicotinic acid and codehydrogenase (coenzymase) in blood to pellagrins and normal persons. JAMA 1939; 112: 420–2
   Google Scholar
• Evans VL. Pellagra with psychosis and minimal physical symptoms. JAMA Apr 1, 1939; 1249–50
   Google Scholar
• Sutton DC. Interrelationship between the vitamin B complex and the anterior lobe of the pituitary gland. J Lab Clin Med 1940; 25(11)1188–92
   Google Scholar
• Spies TD. The role of nicotinic acid in the prevention of pellagra, roentigen sickness and increased porphyrinuria. J Clin Invest 1939; 17
   Google Scholar
• Neuwahl FJ. Action of nicotinic acid on carbohydrate metabolism. Lancet Sept 18, 1943; 348–51
   Google Scholar
• Cleary JP. The NAD deficiency diseases. J Orthomol Med 1986; Vol. 1/3: 149–53
   Google Scholar
• Winegrad A. Banting Lecture 1986. Does a Common Mechanism Induce the Diverse Complications of Diabetes?. Diabetes 1987; 36: 396–406
   PubMed Web of Science ®Google Scholar
• Vilter R. W., et al. Determination of codehydrogenases I and II (coenzymase in the blood of diabetics in severe acidosis). Am J Med Sci 1939; 197: 322–6
   Google Scholar
• Jenkins R. 1986; 798, Puridine nucleotide levels in the diabetic heart, kidney, liver and diaphragm. Diabetes conf paper
   Google Scholar
• Fu C. S., et al. Biochemical markers for assessment of niacin status in young men: levels of erythrocyte niacin co-enzymes and plasma tryptophan. J Nutr 1989; 119: 945–55
   Google Scholar
• Obrosova IG. Nicotinamide coenzyme regulation of sorbital pathways to glucose metabolism in the aorta of rats with streptozotocin diabetes. Vorp Med Khim Mar-Apr 28, 1985; 31(2)125–8, (Russian with English Abstract.)
   PubMedGoogle Scholar
• Yamamoto H, et al. Protection by picolinamide, a novel inhibitor of poly(ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets. Academic Press, New York 1980; lx/80/1: 006–29; 130474–08
   Google Scholar
• Nakajima H, et al. Elevated antibody-dependent cell-mediated cytotoxicity and its inhibition by nicotinamide in the diabetic NOD mouse. Immunol Lett 1986; 12: 91–4
   PubMedGoogle Scholar
• Wahlberg G. Protective effect of nicotinamide against nephropathy in diabetic rats. Diabetes Res 1985; 2(6)306–12
   Google Scholar
• Vague P. H., et al. Nicotinamide may extend remission phase of insulin-dependent diabetes. Lancet Mar 14, 1987; 619
   PubMedGoogle Scholar
• Lazarow A. Protection Against Diabetes with Nicotiniamide. Dept. of Anatomy, Western Reserve University. April, 1950
   Google Scholar
• Sandler S, et al. Tissue Culture of Human Fetal Pancreas. Diabetes Jan, 1989; 38, Suppl. 1
   Google Scholar
• Yamada K, et al. Preventive and therapeutic effect of large-dose nicotinamide injection on diabetics associated with insulitis. Diabetes Sept, 1982; 31
   PubMedGoogle Scholar
• Uchigata Y, et al. Effect of poly(ADP-ribose) synthetase inhibitor administration of nicotinamide to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes April, 1983; 32
   PubMedGoogle Scholar
• Lazarus S. S., et al. Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity. Diabetes 1973; 22(7)
   Google Scholar
• Yonemura Y, et al. Amelioration of diabetes mellitus in partially depancreatized rates by poly(ADP-ribose) synthetase inhibition. Diabetes Apr, 1984; 33
   PubMedGoogle Scholar
• Elliot R. B., et al (1988) Successful prevention and cure of diabetes in the NOD mouse. IDF Satellite Meeting, 9th International Workshop on Immunology of Diabetes. 1988. MelbourneAustralia
   Google Scholar
• Pozzilli P, et al. Nicotinamide therapy in patients with newly diagnosed type I (insulin-dependent) diabetes (meeting abstract). Diabetalog 1988; 31: 533
   Google Scholar
• Rorsman P, et al. Glucose-inhibition of glucagon secretion involves activation of GABA-receptor chloride channels. Nature Sept, 1989; 341: 21
   Google Scholar
• Gross R. C., et al. Metabolic effects of nicotinic acid in acute insulin deficiency in the rat. Diabetes 1968; 17(6)353
   PubMedGoogle Scholar
• Lopez-Moratalla N, et al. Effect of injected glucagon on fatty acids on mitochondrial ATPase. Archiv Biochem Biophys 1984; 229(1)194–201
   PubMedGoogle Scholar
• Waterman R, et al. Effects of nicotinic acid on ketotic cows. Dairy Sci 1970; 53: 650
   Google Scholar
• Rosenbloom A. Intracerebral crisis during RX of diabetic ketoacidosis. Diabetes Care 1990; 13: 22–33
   PubMed Web of Science ®Google Scholar
• Smith SR. Severe hypertriglyceridemia responding to insulin and nicotinic acid therapy. Postgrad Med H. Aug 57, 1981; 511–5
   Google Scholar
• Kamada T. Dietary sardine oil increases erythrocytes membrane fluidity in diabetic patients. Diabetes 1986; 35: 604–10
   PubMed Web of Science ®Google Scholar
• Rudin DO. The major psychoses and neuroses as omega 3 EFA deficiency syndrome substrate pellagra Biol Psych 1981; 16: 837. The modernization disease syndrome as substrate pellagra-beriberi. J Orthomol Med 1987; 2(1)3–14
   Google Scholar
• O'Dea K. Diabetes in Australian Aborigines. Diabetes 1984; 33: 596–603
   PubMed Web of Science ®Google Scholar
• Trishitta V. ATP and other nucleoside triphosphates inhibit the binding of insulin to its receptor. Metabolism 1984; 33(6)577–81
   PubMedGoogle Scholar
• Schaufstetter IU. Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury in cells. J Clin Invest 1986; 76(3)1131–9
   Google Scholar
• Greene D. A., et al. Sorbital, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. Seminars in Medicine of the Beth Israel Hospital, Boston. NEJM Mar 5, 1987; 599–606
   PubMedGoogle Scholar
• Boquist, et al. Structural B-cell changes and transient hyperglycemia in mice treated with compounds inducing inhibited citric acid cycle enzyme activity. Diabetes 1988; 37: 89–98
   PubMed Web of Science ®Google Scholar
• Reaven G. M., et al. Additive hypoglycemic effects of drugs that modify free fatty acid metabolism by different mechanisms in rats with STZ-induced diabetes. Diabetes 1988; 37: 28–32
   PubMed Web of Science ®Google Scholar
• Elliot R. B., et al. The effect of nicotinamide on newly diagnosed children with diabetes. IDF Satellite Meeting, 9th International Workshop on Immunology of Diabetes. Sydney, Australia, 1988. Effect of nicotinamide in preventing diabetes (IDDM) in children. IDF Satellite Meeting, 9th International Workshop in Immunology of Diabetes. 1988. MelbourneAustralia November, 1988
   Google Scholar
• Roe DA. Diet nutrition and drug reactions. Modern Nutrition in Health and Disease, 7th Edn, 1988, ME Shils, VR Young. Lea & Febiger, Philadelphia 1988; 631
   Google Scholar
• Hankes LV. Nicotinic acid and nicotinamide. Handbook of Vitamins: Nutritional, Biochemical and Clinical Aspects, LJ Machlin. Marcel Dekker, New York 1984; 329–377
   Google Scholar